JA2-WP5 EUnetHTA Joint Action 2 (2012-15)
2013 - PDF

The purpose of the assessment is to evaluate Zostavax® for the prevention of herpes zoster.

Final version of the assessment was published in September 2013

Below is the documentation provided by the Joint Assessment authoring team: